Literature DB >> 18299497

Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With The Guidelines" program.

Kenneth A LaBresh1, Mathew J Reeves, Michael R Frankel, Dawn Albright, Lee H Schwamm.   

Abstract

BACKGROUND: Adherence to evidence-based interventions for hospitalized patients who have experienced a stroke is suboptimal. We examined the association of process improvement and Internet-based data collection and decision support with stroke care.
METHODS: A 1-year intervention study to assess performance measure adherence in hospitals using the "Get With The Guidelines-Stroke" program. The program included 18 410 patients with ischemic stroke or transient ischemic attack admitted to 99 volunteer community and teaching hospitals. Data from eligible patients in the preintervention baseline period were compared with data from 4 subsequent quarters for 12 acute care or secondary prevention measures and an all-or-none measure of care based on 7 prespecified measures.
RESULTS: Significant improvements from baseline to the fourth quarter were seen in 11 of 13 measures: use of thrombolytic medications for patients with ischemic stroke presenting within 2 hours of onset, 23.5% vs 40.8% (P < .001); early use of antithrombotic medications, 88.2% vs 95.2% (P < .001); antithrombotic medications prescribed at discharge, 91.0% vs 97.9% (P < .001); anticoagulation agents for atrial fibrillation, 81.4% vs 96.5% (P < .001); smoking cessation counseling, 38.3% vs 54.5% (P < .001); lipid treatment for low-density lipoprotein levels 100 mg/dL or greater, 58.7% vs 77.0% (P < .001); diabetes mellitus treatment, 48.5% vs 83.5% (P = .001); and weight reduction counseling 32.5% vs 43.4% (P < .001). The all-or-none measure increased from 50.2% to 58.0% (P < .001). Complications from thrombolytic medications and prophylaxis for deep venous thrombosis did not change.
CONCLUSION: Statistically and clinically significant improvement in 11 of 13 quality improvement measures for the treatment of patients hospitalized for cerebrovascular disease was seen in hospitals participating in the Get With The Guidelines program.

Entities:  

Mesh:

Year:  2008        PMID: 18299497     DOI: 10.1001/archinternmed.2007.101

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  49 in total

1.  Preventing recurrence of thromboembolic events through coordinated treatment in the District of Columbia.

Authors:  Alexander W Dromerick; Michael C Gibbons; Dorothy F Edwards; Deeonna E Farr; Margot L Giannetti; Brisa Sánchez; Nawar M Shara; Ali Fokar; Annapurni Jayam-Trouth; Bruce Ovbiagele; Chelsea S Kidwell
Journal:  Int J Stroke       Date:  2011-10       Impact factor: 5.266

2.  Use of antithrombotic medications among elderly ischemic stroke patients.

Authors:  Judith H Lichtman; Lisa Naert; Norrina B Allen; Emi Watanabe; Sara B Jones; Lisa C Barry; Dawn M Bravata; Larry B Goldstein
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-11-23

3.  [Principles of the developmental process and implementation of guidelines. An update].

Authors:  I Kopp
Journal:  Radiologe       Date:  2008-11       Impact factor: 0.635

4.  The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset.

Authors:  Jeffrey L Saver; Eric E Smith; Gregg C Fonarow; Mathew J Reeves; Xin Zhao; Daiwai M Olson; Lee H Schwamm
Journal:  Stroke       Date:  2010-06-03       Impact factor: 7.914

5.  Ambulatory treatment gaps in patients with ischemic stroke or transient ischemic attack.

Authors:  Kari L Olson; Lisa J Lash; Thomas Delate; Michele Wood; Jon Rasmussen; Anne M Denham; John A Merenich
Journal:  Perm J       Date:  2013

6.  30-day mortality and readmission after hemorrhagic stroke among Medicare beneficiaries in Joint Commission primary stroke center-certified and noncertified hospitals.

Authors:  Judith H Lichtman; Sara B Jones; Erica C Leifheit-Limson; Yun Wang; Larry B Goldstein
Journal:  Stroke       Date:  2011-10-27       Impact factor: 7.914

Review 7.  Regulatory, legislative, and policy updates with anticoagulant use.

Authors:  John Fanikos; Leo F Buckley; Ahmed Aldemerdash; Kimberly J Terry; Gregory Piazza; Jean M Connors; Samuel Z Goldhaber
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

8.  Assessment and management of febrile neutropenia in emergency departments within a regional health authority-a benchmark analysis.

Authors:  D Szwajcer; P Czaykowski; D Turner
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

9.  Comparing and ranking hospitals based on outcome: results from The Netherlands Stroke Survey.

Authors:  H F Lingsma; E W Steyerberg; M J C Eijkemans; D W J Dippel; W J M Scholte Op Reimer; H C Van Houwelingen
Journal:  QJM       Date:  2009-12-11

10.  Use, Temporal Trends, and Outcomes of Endovascular Therapy After Interhospital Transfer in the United States.

Authors:  Shreyansh Shah; Ying Xian; Shubin Sheng; Kori S Zachrison; Jeffrey L Saver; Kevin N Sheth; Gregg C Fonarow; Lee H Schwamm; Eric E Smith
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.